Cite

HARVARD Citation

    Kallis, M. et al. (2020). Gefitinib treatment reverses post-surgical pro-metastatic immune changes and improves survival in a mouse model of osteosarcoma. International journal of surgery. pp. 271-. [Online]. 
  
Back to record